Literature DB >> 21420562

The secret trumps, impelling the pathogenicity of tubercle bacilli.

Pere-Joan Cardona1, Juraj Ivanyi.   

Abstract

Confrontation between invading microbial pathogens and host defense systems involves intricate cellular and molecular interactions. Here we discuss the virulence factors as trumps, overriding the contest in favor of the tubercle bacillus (Mycobacterium tuberculosis). It evolved a number of molecular constituents, which can interfere with antigen presentation and Toll receptor function, thus impairing immune defenses. It also evolved stress responses, which can drive its cell cycle into a non-replicating, low metabolic mode. Although the low counts of latent bacilli prevent their direct detection, we contend that they retain a capacity to survive for long periods in foamy macrophages and within the necrotic parts of lung granulomas. We attributed significance to drainage of M. tuberculosis by the alveolar fluid: while out-flow is responsible for the clearance, the reverse-flow has an important capacity to re-infect the lungs and to transmit the infection to new recipients. We consider the cycling between replicating and latent organisms to be a continuous process, which is a departure from the concept of long-lived dormant organisms, with a capacity to resuscitate. These aspects impinge also on the actions of isoniazid (INH) chemotherapy and on the topography of human lung lesions. Eventually, fibrosis of the connective tissue of the lungs is known to encapsulate lung lesions, thus limiting the impact of both outward and reverse drainage. In conclusion, the novelty of our views on M. tuberculosis-host interactions rests in the dynamic perception of M. tuberculosis latency and its evolutionary importance for the pathogenesis of tuberculosis.
Copyright © 2011 Elsevier España S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420562     DOI: 10.1016/S0213-005X(11)70013-1

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  8 in total

Review 1.  Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.

Authors:  Satria A Prabowo; Matthias I Gröschel; Ed D L Schmidt; Alena Skrahina; Traian Mihaescu; Serap Hastürk; Rotislav Mitrofanov; Edita Pimkina; Ildikó Visontai; Bouke de Jong; John L Stanford; Père-Joan Cardona; Stefan H E Kaufmann; Tjip S van der Werf
Journal:  Med Microbiol Immunol       Date:  2012-11-10       Impact factor: 3.402

2.  Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages.

Authors:  Mi-Sun Koo; Selvakumar Subbian; Gilla Kaplan
Journal:  Cell Commun Signal       Date:  2012-01-26       Impact factor: 5.712

Review 3.  The key role of exudative lesions and their encapsulation: lessons learned from the pathology of human pulmonary tuberculosis.

Authors:  Pere-Joan Cardona
Journal:  Front Microbiol       Date:  2015-06-16       Impact factor: 5.640

4.  To achieve an earlier IFN-γ response is not sufficient to control Mycobacterium tuberculosis infection in mice.

Authors:  Cristina Vilaplana; Clara Prats; Elena Marzo; Carles Barril; Marina Vegué; Jorge Diaz; Joaquim Valls; Daniel López; Pere-Joan Cardona
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

Review 5.  The Progress of Therapeutic Vaccination with Regard to Tuberculosis.

Authors:  Pere-Joan Cardona
Journal:  Front Microbiol       Date:  2016-09-28       Impact factor: 5.640

6.  Local Inflammation, Dissemination and Coalescence of Lesions Are Key for the Progression toward Active Tuberculosis: The Bubble Model.

Authors:  Clara Prats; Cristina Vilaplana; Joaquim Valls; Elena Marzo; Pere-Joan Cardona; Daniel López
Journal:  Front Microbiol       Date:  2016-02-02       Impact factor: 5.640

7.  Within the Enemy's Camp: contribution of the granuloma to the dissemination, persistence and transmission of Mycobacterium tuberculosis.

Authors:  Christopher R Shaler; Carly N Horvath; Mangalakumari Jeyanathan; Zhou Xing
Journal:  Front Immunol       Date:  2013-02-14       Impact factor: 7.561

Review 8.  The lack of a big picture in tuberculosis: the clinical point of view, the problems of experimental modeling and immunomodulation. The factors we should consider when designing novel treatment strategies.

Authors:  Cristina Vilaplana; Pere-Joan Cardona
Journal:  Front Microbiol       Date:  2014-02-14       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.